Company Filing History:
1 out of 133 
1 out of 441 
Years Active: 2024
Title: Mayumi Sue: Innovator in Antibody Research
Introduction
Mayumi Sue is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of antibody research, particularly in the development of therapeutic agents for cancer treatment. Her innovative work has garnered attention in the scientific community.
Latest Patents
Mayumi Sue holds a patent for an anti-SIRPα antibody. This antibody can be utilized as a tumor agent and an anti-tumor agent, comprising the antibody as an active ingredient. The invention specifically targets human SIRPα to inhibit its binding to CD47, which is crucial in cancer therapy.
Career Highlights
Throughout her career, Mayumi Sue has worked with esteemed institutions such as Kobe University and Daiichi Sankyo Company, Limited. Her experience in these organizations has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Mayumi has collaborated with notable colleagues, including Takashi Matozaki and Kensuke Nakamura. These partnerships have enriched her research and expanded the impact of her work in the field of antibody development.
Conclusion
Mayumi Sue's innovative contributions to antibody research highlight her role as a leading inventor in the scientific community. Her work continues to pave the way for advancements in cancer treatment and therapeutic applications.